New Drug Application submitted for first-ever Progeria treatment
A New Drug Application has been submitted to the FDA for lonafarnib, the first-ever treatment for Progeria and Progeroid Laminopathies.
List view / Grid view
A New Drug Application has been submitted to the FDA for lonafarnib, the first-ever treatment for Progeria and Progeroid Laminopathies.
A trial has shown that radiotherapy is more effective when levels of ropidoxuridine in a patients' body reach a certain level...
Clinical trial results provide evidence that using the generic skin cream fluorouacil 5 percent for two to four weeks may reduce the risk of SCC...